The global market for Personalized mRNA Cancer Vaccine Therapy was valued at US$ 1347 million in the year 2024 and is projected to reach a revised size of US$ 1976 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Personalized mRNA Cancer Vaccine Therapy Market

Personalized mRNA Cancer Vaccine Therapy is a vaccine designed for individual patients' tumor-specific antigens. This vaccine extracts tumor tissue samples from patients, analyzes the gene mutations and protein expressions within, and identifies the unique antigens of the tumor. Using mRNA technology, it then delivers the coding information of these antigens to the patient's immune cells, stimulating them to produce an immune response against these specific antigens. Since the vaccine is designed based on the individual tumor characteristics of the patient, it is highly personalized and targeted. Personalized mRNA Cancer Vaccines have shown potential in treating various types of cancer, offering new treatment options and potentially prolonging survival for patients.

North American market for Personalized mRNA Cancer Vaccine Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Personalized mRNA Cancer Vaccine Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Personalized mRNA Cancer Vaccine Therapy include Moderna, BioNTech, Neocura, Everest Medicines, Curevac, Genentech, Merck, Transgene, Likang Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Personalized mRNA Cancer Vaccine Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized mRNA Cancer Vaccine Therapy.

The Personalized mRNA Cancer Vaccine Therapy market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized mRNA Cancer Vaccine Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized mRNA Cancer Vaccine Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Personalized mRNA Cancer Vaccine Therapy Market Report

Report Metric	Details
Report Name	Personalized mRNA Cancer Vaccine Therapy Market
Accounted market size in year	US$ 1347 million
Forecasted market size in 2031	US$ 1976 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	LNP Delivery System DC Cell Delivery System Others
Segment by Application	Solid Tumors Non-Solid Tumors
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Moderna, BioNTech, Neocura, Everest Medicines, Curevac, Genentech, Merck, Transgene, Likang Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Personalized mRNA Cancer Vaccine Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Personalized mRNA Cancer Vaccine Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Personalized mRNA Cancer Vaccine Therapy Market growing?

Ans: The Personalized mRNA Cancer Vaccine Therapy Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Personalized mRNA Cancer Vaccine Therapy Market size in 2031?

Ans: The Personalized mRNA Cancer Vaccine Therapy Market size in 2031 will be US$ 1976 million.

Who are the main players in the Personalized mRNA Cancer Vaccine Therapy Market report?

Ans: The main players in the Personalized mRNA Cancer Vaccine Therapy Market are Moderna, BioNTech, Neocura, Everest Medicines, Curevac, Genentech, Merck, Transgene, Likang Life Sciences

What are the Application segmentation covered in the Personalized mRNA Cancer Vaccine Therapy Market report?

Ans: The Applications covered in the Personalized mRNA Cancer Vaccine Therapy Market report are Solid Tumors, Non-Solid Tumors

What are the Type segmentation covered in the Personalized mRNA Cancer Vaccine Therapy Market report?

Ans: The Types covered in the Personalized mRNA Cancer Vaccine Therapy Market report are LNP Delivery System, DC Cell Delivery System, Others

1 Personalized mRNA Cancer Vaccine Therapy Market Overview

1.1 Product Definition

1.2 Personalized mRNA Cancer Vaccine Therapy by Type

1.2.1 Global Personalized mRNA Cancer Vaccine Therapy Market Value Comparison by Type (2024 VS 2031)

1.2.2 LNP Delivery System

1.2.3 DC Cell Delivery System

1.2.4 Others

1.3 Personalized mRNA Cancer Vaccine Therapy by Application

1.3.1 Global Personalized mRNA Cancer Vaccine Therapy Market Value by Application (2024 VS 2031)

1.3.2 Solid Tumors

1.3.3 Non-Solid Tumors

1.4 Global Personalized mRNA Cancer Vaccine Therapy Market Size Estimates and Forecasts

1.4.1 Global Personalized mRNA Cancer Vaccine Therapy Revenue 2020-2031

1.4.2 Global Personalized mRNA Cancer Vaccine Therapy Sales 2020-2031

1.4.3 Global Personalized mRNA Cancer Vaccine Therapy Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Personalized mRNA Cancer Vaccine Therapy Market Competition by Manufacturers

2.1 Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Manufacturers (2020-2025)

2.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Personalized mRNA Cancer Vaccine Therapy Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Personalized mRNA Cancer Vaccine Therapy, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Product Type & Application

2.7 Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Date of Enter into This Industry

2.8 Global Personalized mRNA Cancer Vaccine Therapy Market Competitive Situation and Trends

2.8.1 Global Personalized mRNA Cancer Vaccine Therapy Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Personalized mRNA Cancer Vaccine Therapy Players Market Share by Revenue

2.8.3 Global Personalized mRNA Cancer Vaccine Therapy Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Personalized mRNA Cancer Vaccine Therapy Market Scenario by Region

3.1 Global Personalized mRNA Cancer Vaccine Therapy Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Personalized mRNA Cancer Vaccine Therapy Sales by Region: 2020-2031

3.2.1 Global Personalized mRNA Cancer Vaccine Therapy Sales by Region: 2020-2025

3.2.2 Global Personalized mRNA Cancer Vaccine Therapy Sales by Region: 2026-2031

3.3 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region: 2020-2031

3.3.1 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region: 2020-2025

3.3.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region: 2026-2031

3.4 North America Personalized mRNA Cancer Vaccine Therapy Market Facts & Figures by Country

3.4.1 North America Personalized mRNA Cancer Vaccine Therapy Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2031)

3.4.3 North America Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Personalized mRNA Cancer Vaccine Therapy Market Facts & Figures by Country

3.5.1 Europe Personalized mRNA Cancer Vaccine Therapy Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2031)

3.5.3 Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Personalized mRNA Cancer Vaccine Therapy Market Facts & Figures by Region

3.6.1 Asia Pacific Personalized mRNA Cancer Vaccine Therapy Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Personalized mRNA Cancer Vaccine Therapy Sales by Region (2020-2031)

3.6.3 Asia Pacific Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Personalized mRNA Cancer Vaccine Therapy Market Facts & Figures by Country

3.7.1 Latin America Personalized mRNA Cancer Vaccine Therapy Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2031)

3.7.3 Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Market Facts & Figures by Country

3.8.1 Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2031)

3.8.3 Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2031)

4.1.1 Global Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2025)

4.1.2 Global Personalized mRNA Cancer Vaccine Therapy Sales by Type (2026-2031)

4.1.3 Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)

4.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2031)

4.2.1 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2025)

4.2.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2026-2031)

4.2.3 Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)

4.3 Global Personalized mRNA Cancer Vaccine Therapy Price by Type (2020-2031)

5 Segment by Application

5.1 Global Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2031)

5.1.1 Global Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2025)

5.1.2 Global Personalized mRNA Cancer Vaccine Therapy Sales by Application (2026-2031)

5.1.3 Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)

5.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2031)

5.2.1 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2025)

5.2.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2026-2031)

5.2.3 Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)

5.3 Global Personalized mRNA Cancer Vaccine Therapy Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Moderna

6.1.1 Moderna Company Information

6.1.2 Moderna Description and Business Overview

6.1.3 Moderna Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Moderna Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.1.5 Moderna Recent Developments/Updates

6.2 BioNTech

6.2.1 BioNTech Company Information

6.2.2 BioNTech Description and Business Overview

6.2.3 BioNTech Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.2.4 BioNTech Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.2.5 BioNTech Recent Developments/Updates

6.3 Neocura

6.3.1 Neocura Company Information

6.3.2 Neocura Description and Business Overview

6.3.3 Neocura Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Neocura Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.3.5 Neocura Recent Developments/Updates

6.4 Everest Medicines

6.4.1 Everest Medicines Company Information

6.4.2 Everest Medicines Description and Business Overview

6.4.3 Everest Medicines Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Everest Medicines Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.4.5 Everest Medicines Recent Developments/Updates

6.5 Curevac

6.5.1 Curevac Company Information

6.5.2 Curevac Description and Business Overview

6.5.3 Curevac Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Curevac Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.5.5 Curevac Recent Developments/Updates

6.6 Genentech

6.6.1 Genentech Company Information

6.6.2 Genentech Description and Business Overview

6.6.3 Genentech Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Genentech Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.6.5 Genentech Recent Developments/Updates

6.7 Merck

6.7.1 Merck Company Information

6.7.2 Merck Description and Business Overview

6.7.3 Merck Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Transgene

6.8.1 Transgene Company Information

6.8.2 Transgene Description and Business Overview

6.8.3 Transgene Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Transgene Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.8.5 Transgene Recent Developments/Updates

6.9 Likang Life Sciences

6.9.1 Likang Life Sciences Company Information

6.9.2 Likang Life Sciences Description and Business Overview

6.9.3 Likang Life Sciences Personalized mRNA Cancer Vaccine Therapy Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Likang Life Sciences Personalized mRNA Cancer Vaccine Therapy Product Portfolio

6.9.5 Likang Life Sciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Personalized mRNA Cancer Vaccine Therapy Industry Chain Analysis

7.2 Personalized mRNA Cancer Vaccine Therapy Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Personalized mRNA Cancer Vaccine Therapy Production Mode & Process Analysis

7.4 Personalized mRNA Cancer Vaccine Therapy Sales and Marketing

7.4.1 Personalized mRNA Cancer Vaccine Therapy Sales Channels

7.4.2 Personalized mRNA Cancer Vaccine Therapy Distributors

7.5 Personalized mRNA Cancer Vaccine Therapy Customer Analysis

8 Personalized mRNA Cancer Vaccine Therapy Market Dynamics

8.1 Personalized mRNA Cancer Vaccine Therapy Industry Trends

8.2 Personalized mRNA Cancer Vaccine Therapy Market Drivers

8.3 Personalized mRNA Cancer Vaccine Therapy Market Challenges

8.4 Personalized mRNA Cancer Vaccine Therapy Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Personalized mRNA Cancer Vaccine Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Personalized mRNA Cancer Vaccine Therapy Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Personalized mRNA Cancer Vaccine Therapy Market Competitive Situation by Manufacturers in 2024

Table 4. Global Personalized mRNA Cancer Vaccine Therapy Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Personalized mRNA Cancer Vaccine Therapy Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Personalized mRNA Cancer Vaccine Therapy Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Personalized mRNA Cancer Vaccine Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Personalized mRNA Cancer Vaccine Therapy, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Product Type & Application

Table 12. Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Personalized mRNA Cancer Vaccine Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized mRNA Cancer Vaccine Therapy as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Personalized mRNA Cancer Vaccine Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Personalized mRNA Cancer Vaccine Therapy Sales by Region (2020-2025) & (Units)

Table 18. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Region (2020-2025)

Table 19. Global Personalized mRNA Cancer Vaccine Therapy Sales by Region (2026-2031) & (Units)

Table 20. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Region (2026-2031)

Table 21. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Region (2020-2025)

Table 23. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Region (2026-2031)

Table 25. North America Personalized mRNA Cancer Vaccine Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2025) & (Units)

Table 27. North America Personalized mRNA Cancer Vaccine Therapy Sales by Country (2026-2031) & (Units)

Table 28. North America Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2025) & (Units)

Table 32. Europe Personalized mRNA Cancer Vaccine Therapy Sales by Country (2026-2031) & (Units)

Table 33. Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Personalized mRNA Cancer Vaccine Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Personalized mRNA Cancer Vaccine Therapy Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Personalized mRNA Cancer Vaccine Therapy Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2025) & (Units)

Table 42. Latin America Personalized mRNA Cancer Vaccine Therapy Sales by Country (2026-2031) & (Units)

Table 43. Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Personalized mRNA Cancer Vaccine Therapy Sales (Units) by Type (2020-2025)

Table 51. Global Personalized mRNA Cancer Vaccine Therapy Sales (Units) by Type (2026-2031)

Table 52. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2025)

Table 53. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2026-2031)

Table 54. Global Personalized mRNA Cancer Vaccine Therapy Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Personalized mRNA Cancer Vaccine Therapy Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2025)

Table 57. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2026-2031)

Table 58. Global Personalized mRNA Cancer Vaccine Therapy Price (US$/Unit) by Type (2020-2025)

Table 59. Global Personalized mRNA Cancer Vaccine Therapy Price (US$/Unit) by Type (2026-2031)

Table 60. Global Personalized mRNA Cancer Vaccine Therapy Sales (Units) by Application (2020-2025)

Table 61. Global Personalized mRNA Cancer Vaccine Therapy Sales (Units) by Application (2026-2031)

Table 62. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2025)

Table 63. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2026-2031)

Table 64. Global Personalized mRNA Cancer Vaccine Therapy Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Personalized mRNA Cancer Vaccine Therapy Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2025)

Table 67. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2026-2031)

Table 68. Global Personalized mRNA Cancer Vaccine Therapy Price (US$/Unit) by Application (2020-2025)

Table 69. Global Personalized mRNA Cancer Vaccine Therapy Price (US$/Unit) by Application (2026-2031)

Table 70. Moderna Company Information

Table 71. Moderna Description and Business Overview

Table 72. Moderna Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Moderna Personalized mRNA Cancer Vaccine Therapy Product

Table 74. Moderna Recent Developments/Updates

Table 75. BioNTech Company Information

Table 76. BioNTech Description and Business Overview

Table 77. BioNTech Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. BioNTech Personalized mRNA Cancer Vaccine Therapy Product

Table 79. BioNTech Recent Developments/Updates

Table 80. Neocura Company Information

Table 81. Neocura Description and Business Overview

Table 82. Neocura Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Neocura Personalized mRNA Cancer Vaccine Therapy Product

Table 84. Neocura Recent Developments/Updates

Table 85. Everest Medicines Company Information

Table 86. Everest Medicines Description and Business Overview

Table 87. Everest Medicines Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Everest Medicines Personalized mRNA Cancer Vaccine Therapy Product

Table 89. Everest Medicines Recent Developments/Updates

Table 90. Curevac Company Information

Table 91. Curevac Description and Business Overview

Table 92. Curevac Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Curevac Personalized mRNA Cancer Vaccine Therapy Product

Table 94. Curevac Recent Developments/Updates

Table 95. Genentech Company Information

Table 96. Genentech Description and Business Overview

Table 97. Genentech Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Genentech Personalized mRNA Cancer Vaccine Therapy Product

Table 99. Genentech Recent Developments/Updates

Table 100. Merck Company Information

Table 101. Merck Description and Business Overview

Table 102. Merck Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Merck Personalized mRNA Cancer Vaccine Therapy Product

Table 104. Merck Recent Developments/Updates

Table 105. Transgene Company Information

Table 106. Transgene Description and Business Overview

Table 107. Transgene Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Transgene Personalized mRNA Cancer Vaccine Therapy Product

Table 109. Transgene Recent Developments/Updates

Table 110. Likang Life Sciences Company Information

Table 111. Likang Life Sciences Description and Business Overview

Table 112. Likang Life Sciences Personalized mRNA Cancer Vaccine Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Likang Life Sciences Personalized mRNA Cancer Vaccine Therapy Product

Table 114. Likang Life Sciences Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Personalized mRNA Cancer Vaccine Therapy Distributors List

Table 118. Personalized mRNA Cancer Vaccine Therapy Customers List

Table 119. Personalized mRNA Cancer Vaccine Therapy Market Trends

Table 120. Personalized mRNA Cancer Vaccine Therapy Market Drivers

Table 121. Personalized mRNA Cancer Vaccine Therapy Market Challenges

Table 122. Personalized mRNA Cancer Vaccine Therapy Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Personalized mRNA Cancer Vaccine Therapy

Figure 2. Global Personalized mRNA Cancer Vaccine Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Personalized mRNA Cancer Vaccine Therapy Market Share by Type: 2024 & 2031

Figure 4. LNP Delivery System Product Picture

Figure 5. DC Cell Delivery System Product Picture

Figure 6. Others Product Picture

Figure 7. Global Personalized mRNA Cancer Vaccine Therapy Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Personalized mRNA Cancer Vaccine Therapy Market Share by Application: 2024 & 2031

Figure 9. Solid Tumors

Figure 10. Non-Solid Tumors

Figure 11. Global Personalized mRNA Cancer Vaccine Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Personalized mRNA Cancer Vaccine Therapy Market Size (2020-2031) & (US$ Million)

Figure 13. Global Personalized mRNA Cancer Vaccine Therapy Sales (2020-2031) & (Units)

Figure 14. Global Personalized mRNA Cancer Vaccine Therapy Average Price (US$/Unit) & (2020-2031)

Figure 15. Personalized mRNA Cancer Vaccine Therapy Report Years Considered

Figure 16. Personalized mRNA Cancer Vaccine Therapy Sales Share by Manufacturers in 2024

Figure 17. Global Personalized mRNA Cancer Vaccine Therapy Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Personalized mRNA Cancer Vaccine Therapy Players: Market Share by Revenue in Personalized mRNA Cancer Vaccine Therapy in 2024

Figure 19. Personalized mRNA Cancer Vaccine Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Personalized mRNA Cancer Vaccine Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Country (2020-2031)

Figure 22. North America Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Country (2020-2031)

Figure 23. United States Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Country (2020-2031)

Figure 26. Europe Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Country (2020-2031)

Figure 27. Germany Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Region (2020-2031)

Figure 34. China Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Country (2020-2031)

Figure 42. Latin America Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Personalized mRNA Cancer Vaccine Therapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Personalized mRNA Cancer Vaccine Therapy by Type (2020-2031)

Figure 53. Global Revenue Market Share of Personalized mRNA Cancer Vaccine Therapy by Type (2020-2031)

Figure 54. Global Personalized mRNA Cancer Vaccine Therapy Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Personalized mRNA Cancer Vaccine Therapy by Application (2020-2031)

Figure 56. Global Revenue Market Share of Personalized mRNA Cancer Vaccine Therapy by Application (2020-2031)

Figure 57. Global Personalized mRNA Cancer Vaccine Therapy Price (US$/Unit) by Application (2020-2031)

Figure 58. Personalized mRNA Cancer Vaccine Therapy Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global Personalized Cancer Treatment Market Research Report 2025

Global mRNA Therapy Market Research Report 2024

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global mRNA Treatment Market Research Report 2024

Global Targeted Cancer Therapy Market Research Report 2024

Global Personalized Cell Therapy Market Research Report 2024

Global mRNA Vaccines for Animals Market Research Report 2025

Global Personalized Cancer Medicine Market Research Report 2025

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030

Global Veterinary mRNA Vaccines Market Research Report 2025

Global LNP mRNA Therapy Market Research Report 2025

Global Neoantigen Targeted Therapy Market Research Report 2024

Global mRNA Vaccine Drugs Development Services Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic Cancer Vaccines Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32T20006

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0Q20500

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-18V16958

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Personalized mRNA Cancer Vaccine Therapy Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-29M18889

Global Personalized mRNA Cancer Vaccine Therapy Market Research Report 2025

FEATURED COMPANIES

Personalized mRNA Cancer Vaccine Therapy Market Size

Personalized mRNA Cancer Vaccine Therapy Market

Report Scope

Scope of Personalized mRNA Cancer Vaccine Therapy Market Report

Core Chapters

FAQ for this report

How fast is Personalized mRNA Cancer Vaccine Therapy Market growing?

What is the Personalized mRNA Cancer Vaccine Therapy Market size in 2031?

Who are the main players in the Personalized mRNA Cancer Vaccine Therapy Market report?

What are the Application segmentation covered in the Personalized mRNA Cancer Vaccine Therapy Market report?

What are the Type segmentation covered in the Personalized mRNA Cancer Vaccine Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS